Navigation Links
John C. Moran Named Chairman of the Board at Core Essence Orthopaedics
Date:4/7/2009

YARDLEY, Pa., April 7 /PRNewswire/ -- Core Essence Orthopaedics, Inc., a medical device company focused on soft tissue and skeletal repair of the extremities, today announced that John Moran has joined Core Essence as Chairman of the Board, effective immediately. Moran joins Directors Tony Dimun, Leonard Gordon, M.D., Shawn Huxel and Zev Scherl.

"We are thrilled to welcome a proven leader like John as our board's Chairman," said Shawn Huxel, co-founder and Chief Executive Officer of Core Essence. "John brings nearly 30 years of experience as an executive and investor in the medical device industry to Core Essence. We look forward to his insight and counsel as Core Essence prepares for the commercial launch of its novel portfolio of orthopaedic products over the coming months."

"Core Essence is at an exciting stage of its growth," explained John Moran, Chairman. "With our lead products now cleared for marketing by the FDA, Core Essence is well positioned to participate in the more than $1 billion market opportunity for orthopaedic soft tissue repair. It will be a pleasure to work with the Core Essence team and its Scientific Advisory Board as we commence commercial operations and embark on this next phase of growth."

From 1990-1997, Moran served as President of Synthes Spine Inc., a division of Synthes (USA) that designs, manufactures and distributes implants and instruments for spinal disorders. During Moran's six-year tenure as President, Synthes Spine's revenues grew from approximately $1 million to more than $60 million.

Moran has also been a board member for a number of companies, primarily in the medical device arena, including Spine Solutions, Inc., (the developer of ProDisc). Moran is currently on the board of Paradigm Spine, LLC, Ranier Technology, Anika Therapeutics , and Power Medical Interventions, Inc. Moran is a graduate of the University of Notre Dame and holds an MBA from Harvard University.

    Contact:
    Shawn T. Huxel
    Chief Executive Officer and President
    215.310.9534
    Shawn.Huxel@CEOrtho.com

About Core Essence Orthopaedics, Inc.

Core Essence Orthopaedics, Inc. (CE Ortho) is a privately held orthopaedic device company focused on the development, manufacture and commercialization of solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair for the extremity market. CE Ortho's intuitive and innovative technologies are driven by increasing demands for alternatives to complicated surgical procedures. CE Ortho devices enable surgeons to build on classic and familiar surgical techniques with novel instruments and implants that simplify procedures and can be quickly mastered. The company's proprietary technologies provide solutions to the growing volume of tendon and ligament repairs required by the active lifestyles of patients of all ages. For more company information, please visit www.ceortho.com.


'/>"/>
SOURCE Core Essence Orthopaedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Campaign for Americas Future Memorandum: Katrina Storm Warning
2. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
3. DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India
4. Iraqs Ministry of Health and USAID Sign Memorandum of Understanding to Increase Cooperation in Public Management
5. Intercim and Dassault Systemes Sign Memorandum of Understanding
6. Anita Moran AIA Joins WHR Dallas
7. UCLA signs historic memorandum with pediatric institution in Tokyo
8. Statement on Presidential Memorandum to EPA to Review Lifting of Ban on California Clean Car Standard
9. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
10. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
11. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Columbus OH. ... selected as one of few medical professionals in the country to sit on the ... of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic from ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant ... Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System to ... adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. ...
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium in ... and offered an opportunity to collaborate and network with healthcare colleagues across the United ... gathered for a lively discussion on trends and issues that healthcare leaders will face ...
(Date:3/28/2017)... ... ... Bacteria and fungi are probably not the first ingredients that come to mind when thinking ... in your diet can actually improve health outcomes. And the good news is they may ... a new peer-reviewed paper led by Maria Marco, Ph.D. , University of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... England , March 28, 2017 ... collaborative research with Cambridge ... Therapeutics Consortium   The Milner Therapeutics Institute today ... Consortium. Elysium Health has committed significant investment for collaborative projects ... the next four years. This is the first major research ...
(Date:3/27/2017)... , March 27, 2017 ... better understand Eli Lilly and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: